Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Integrating Internal Strategies to Impact a Successful Product Launch

Your company is ISO 13485 certified and has internal processes in place. Individual departments have well-established SOPs. Yes, you have successfully introduced several products to market on a project-by-project basis. If it’s not broken, why fix it? Why the need to integrate strategies?

“Strategy Integration” has emerged as the new catchphrase in the medical technology sector. As companies face daily challenges of bringing new products to market, they continuously seek ways to drive efficiency, reduce internal costs and expedite product approvals to drive profitability.

In addition to the daily operational activities, successfully launching a product requires the combined efforts of several key functional groups: regulatory affairs, clinical research, reimbursement and marketing. The Regulatory team has to navigate the maze of FDA; Clinical Research is tasked with satisfying enrollment in a timely manner while producing data to meet the needs of key stakeholders, Reimbursement will grapple with the Federal healthcare system for payment constrained within a cost-contained environment, and Marketing has to create a value proposition to produce the return on investment that shareholders expect from forecasted sales.

In the end, the individual strategies of each functional group will impact the others. If the individual strategies are integrated early in the product development phase, the better the chance of a timely, successful launch. The clinical trial protocol will impact FDA clearance. The approved labeling will dictate what is medically necessary for payment. The target market will be determined by who will pay and who will buy. Yes, the needs of FDA, payers and the market are different, but are all very much aligned.

A well-designed, departmentally-integrated strategic plan (a.k.a. your Blueprint) will drive efficiency, decrease time to market and ensure coverage and payment, while driving market adoption and generating revenue, thus increasing company profitability.  We see our business change day to day as a result of many uncontrollable factors in the healthcare environment. It is important to be as flexible as possible with your Blueprint.

There is no one right way to build the strategy; however, several key components are necessary to build the foundation of the plan.

Critical Components of the Blueprint: Your Roadmap to Success

Product Development Phases

Phase I: Conceptualization - The product idea is conceived.

Phase II: Verification - Determining whether the product can be manufactured.

Phase III: Validation - Is the product reproducible, marketable, will it get approved?

Phase IV: Commercialization - Will the product sell? To whom, and for how much?


Milestones do not belong to the individual groups represented, but to the entire organization. Identify what you want to achieve within each product development phase and agree on ownership. It is also critical to put metrics into place to track and analyze the success of the project.